California State Teachers Retirement System Exelixis, Inc. Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Exelixis, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 249,904 shares of EXEL stock, worth $9.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
249,904
Previous 261,098 4.29%
Holding current value
$9.01 Million
Previous $5.87 Million 10.55%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$21.96 - $27.6 $245,820 - $308,954
-11,194 Reduced 4.29%
249,904 $6.49 Million
Q2 2024

Aug 14, 2024
SELL
$20.34 - $23.73 $444,388 - $518,453
-21,848 Reduced 7.72%
261,098 $5.87 Million
Q1 2024

May 15, 2024
SELL
$20.17 - $23.93 $507,416 - $602,007
-25,157 Reduced 8.17%
282,946 $6.71 Million
Q4 2023

Feb 13, 2024
SELL
$19.25 - $24.13 $432,335 - $541,935
-22,459 Reduced 6.79%
308,103 $7.39 Million
Q3 2023

Nov 14, 2023
SELL
$19.04 - $22.74 $642,219 - $767,020
-33,730 Reduced 9.26%
330,562 $7.22 Million
Q2 2023

Aug 21, 2023
SELL
$18.17 - $20.48 $704,959 - $794,583
-38,798 Reduced 9.63%
364,292 $6.96 Million
Q1 2023

May 09, 2023
SELL
$16.3 - $19.41 $62,494 - $74,417
-3,834 Reduced 0.94%
403,090 $7.82 Million
Q4 2022

Feb 14, 2023
BUY
$14.96 - $17.39 $75,936 - $88,271
5,076 Added 1.26%
406,924 $6.53 Million
Q3 2022

Nov 18, 2022
SELL
$15.68 - $22.27 $111,233 - $157,983
-7,094 Reduced 1.73%
401,848 $6.3 Million
Q2 2022

Aug 15, 2022
BUY
$17.44 - $23.16 $110,848 - $147,204
6,356 Added 1.58%
408,942 $8.51 Million
Q1 2022

May 16, 2022
SELL
$17.03 - $22.67 $575,494 - $766,087
-33,793 Reduced 7.74%
402,586 $9.13 Million
Q4 2021

Feb 15, 2022
SELL
$15.84 - $21.88 $1.42 Million - $1.96 Million
-89,513 Reduced 17.02%
436,379 $7.98 Million
Q3 2021

Nov 15, 2021
SELL
$16.3 - $21.14 $181,875 - $235,880
-11,158 Reduced 2.08%
525,892 $11.1 Million
Q2 2021

Aug 16, 2021
SELL
$17.95 - $25.56 $54,496 - $77,600
-3,036 Reduced 0.56%
537,050 $9.79 Million
Q1 2021

May 18, 2021
SELL
$20.53 - $25.22 $38,575 - $47,388
-1,879 Reduced 0.35%
540,086 $12.2 Million
Q4 2020

Feb 16, 2021
BUY
$18.39 - $24.8 $286,387 - $386,210
15,573 Added 2.96%
541,965 $10.9 Million
Q3 2020

Nov 17, 2020
BUY
$20.67 - $26.94 $227,142 - $296,043
10,989 Added 2.13%
526,392 $12.9 Million
Q2 2020

Aug 17, 2020
BUY
$16.46 - $27.42 $234,801 - $391,146
14,265 Added 2.85%
515,403 $12.2 Million
Q1 2020

May 13, 2020
BUY
$14.46 - $21.8 $220,789 - $332,864
15,269 Added 3.14%
501,138 $8.63 Million
Q4 2019

Feb 14, 2020
BUY
$15.15 - $18.89 $121,260 - $151,195
8,004 Added 1.67%
485,869 $8.56 Million
Q3 2019

Nov 15, 2019
BUY
$17.68 - $22.65 $54,648 - $70,011
3,091 Added 0.65%
477,865 $8.45 Million
Q2 2019

Aug 14, 2019
BUY
$18.93 - $24.75 $198,594 - $259,652
10,491 Added 2.26%
474,774 $10.1 Million
Q1 2019

May 09, 2019
BUY
$19.6 - $24.76 $46,197 - $58,359
2,357 Added 0.51%
464,283 $11.1 Million
Q4 2018

Feb 13, 2019
BUY
$13.65 - $21.8 $142,192 - $227,090
10,417 Added 2.31%
461,926 $9.09 Million
Q3 2018

Nov 14, 2018
SELL
$15.87 - $22.4 $2,428 - $3,427
-153 Reduced 0.03%
451,509 $8 Million
Q2 2018

Aug 14, 2018
BUY
$18.56 - $22.45 $70,416 - $85,175
3,794 Added 0.85%
451,662 $9.72 Million
Q1 2018

May 15, 2018
SELL
$22.15 - $31.89 $246,817 - $355,350
-11,143 Reduced 2.43%
447,868 $9.92 Million
Q4 2017

Feb 14, 2018
SELL
$24.23 - $30.93 $157,858 - $201,508
-6,515 Reduced 1.4%
459,011 $14 Million
Q3 2017

Nov 13, 2017
BUY
$23.35 - $29.24 $10.9 Million - $13.6 Million
465,526
465,526 $11.3 Million

Others Institutions Holding EXEL

# of Institutions
503
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email